Susmed Inc. logo

Susmed Inc. (4263)

Market Open
7 Aug, 06:00
JPX JPX
¥
708. 00
+7
+0.9986%
¥
15.89B Market Cap
- P/E Ratio
- Div Yield
53,000 Volume
- Eps
¥ 701
Previous Close
Add Transaction
Day Range
683 710
Year Range
587 1,231
Want to track 4263 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

4263 trading today higher at ¥708, an increase of 0.9986% from yesterday's close, completing a monthly decrease of -15.8145% or -¥133. Over the past 12 months, 4263 stock lost -15.8145%.
4263 is not paying dividends to its shareholders.
The last earnings report, released on May 08, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on JPX (JPY).

4263 Chart

People also search for

Suruga Bank Ltd.
¥ 2,755
+0.7313%
San-In Godo Bank Ltd.
¥ 2,436
-2.7157%
Hokkoku Financial Holdings Inc.
¥ 1,206
-0.659%
Life Corporation Ltd.
¥ 2,611
-0.4575%
Japan Investment Adviser Co., Ltd.
¥ 2,025
+0.7964%

Susmed Inc. (4263) FAQ

What is the stock price today?

The current price is ¥708.00.

On which exchange is it traded?

Susmed Inc. is listed on JPX.

What is its stock symbol?

The ticker symbol is 4263.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 15.89B.

Has Susmed Inc. ever had a stock split?

No, there has never been a stock split.

Susmed Inc. Profile

Insurance Industry
Financials Sector
Mr. Taro Ueno CEO
JPX Exchange
JP3319150003 ISIN
Japan Country
43 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

SUSMED, Inc., established in 2015 and headquartered in Tokyo, Japan, stands at the forefront of the digital therapeutics landscape. The company is dedicated to developing and commercializing innovative therapeutic applications, focusing on enriching patient care through the integration of technology. By harnessing the potential of smartphone-based digital applications, SUSMED aims to address the challenges presented by a variety of diseases, including insomnia, breast cancer, and kidney disease. Alongside its product development efforts, SUSMED extends its expertise to provide medical data analysis and consulting services, driven by a mission to enhance the efficacy of health care solutions through digital innovation.

Products and Services

  • Smartphone Based Digital Therapeutics Applications

    SUSMED leverages mobile technology to create accessible, user-friendly digital therapies. These applications target a range of conditions, such as insomnia, breast cancer, and kidney disease, providing patients with innovative treatment options that complement traditional medical care. Through the convenience of smartphones, SUSMED's applications aim to facilitate improved health outcomes and enhance the quality of life for individuals facing these health challenges.

  • Development Platform for Therapeutic Apps and Clinical Trial Systems

    The company has developed a versatile platform designed to support the creation of therapeutic applications and the management of clinical trials. This platform is a testament to SUSMED's commitment to advancing digital therapeutics by providing a robust foundation for both development and research. By offering these technical resources, SUSMED empowers researchers and developers to explore new frontiers in medical treatment and healthcare optimization.

  • Medical Data Analysis and Consulting Services

    Understanding the critical role of data in healthcare, SUSMED provides comprehensive analysis and consulting services. These services are tailored to assist clients in navigating the complexities of medical data, facilitating informed decision-making and innovative healthcare solutions. With an emphasis on leveraging data for enhanced treatment strategies, SUSMED positions itself as a key player in the movement towards data-driven healthcare.

Contact Information

Address: MFPR Nihonbashi honcho Bldg
Phone: 86 3 6366 7780